Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
 Erratum for Roberts et al., Blood 104 (13) 3858-3864.
Blood, 15 March 2005, Vol. 105, No. 6, pp. 2257.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

ERRATUM

In the article by Roberts et al entitled "The use of recombinant factor VIIa in the treatment of bleeding disorders," which appeared in the December 15, 2004, issue of Blood (Volume 104:3858-3864), the following disclosure was inadvertently omitted by the journal: H.R.R. has been a consultant for and has received an honorarium from Novo Nordisk, the manufacturer of recombinant factor VIIa. He is also a consultant to Baxter Bioscience, which manufactures a competing product, and he has received honoraria from Bayer. G.C.W. is a consultant for and has received honoraria from Baxter Bioscience, Bayer, and Novo Nordisk.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 JBJSHome page
P. K. Gopalan, J. C. Clohisy, A. F. Cashen, and C. S. Eby
Use of Recombinant Factor VIIa for Hip Surgery in a Patient with Factor-VII Deficiency. A Case Report
J. Bone Joint Surg. Am., February 1, 2007; 89(2): 389 - 391.
[Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020